Cognitive Health
Natural health product licensed in Canada
- Licence holder
- Sequence Health Ltd.
- NPN or DIN-HM
- 80073249
- Status
- Active licence
- Licence date
- 25 October 2016
- Revision date
- 3 March 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4'-hydroxy-3,5-diméthoxystilbène Source : Pterostilbene | 100 milligramme | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 9 % Eicosapentaenoic acid | 200 milligramme | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 9 % Eicosapentaenoic acid | 200 milligramme | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 6 % Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 6 % Docosahexaenoic acid | Not specified | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 4,000 milligramme Potency : 24 % Flavonoid glycosides | 80 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 80:1 Dry plant equivalent : 4,000 milligramme Potency : 50 % Epigallocatechin 3-gallate | 50 milligramme | Not calculated |
| Camellia sinensis Source : Feuille Potency : 80 % Catechins | Not specified | Not calculated |
| Acide 3-O-méthylcaféique Source : Ferulic acid | 44 milligramme | Not calculated |
| Euterpe oleracea Source : Fruit | 4 milligramme | Not calculated |
| Chlorella vulgaris Source : Chlorella vulgaris - cellule brisée | 25 milligramme | Not calculated |
| Theobroma cacao Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 16 milligramme | 4 milligramme | Not calculated |
| Vaccinium angustifolium Source : Fruit | 4 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation. Source of/Provides antioxidants. Source of/Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80073249
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging